Trillium Therapeutics Appoints Dr. Ingmar Bruns as Chief Medical Officer

    NEXT STORY
    Immutep’s TACTI-002 Data to Be Presented at Society for Immunotherapy of Cancer 2020 Annual Meeting
    PREV STORY
    Ascendis Pharma A/S Announces Third Quarter 2020 Financial Results and Business Update Conference Call on November 11
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    OSE Immunotherapeutics Presented New Data at AACR* Annual Meeting 2017 on OSE-172 (Effi-DEM), Company’s Checkpoint Inhibitor Blocking Suppressive Myeloid Cells and Inducing Antitumoral Potent T Memory Response

    NANTES, France, April 05, 2017 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics SA (ISIN: FR0012127173) (Mnémo:OSE) ...

    author_avatar
    NASDAQ Market News

    Electronic Lab Notebook (ELN) Market is Expected to Grow at a CAGR of 7% to Reach $642.3 Million by 2025 – Meticulous Research®

    author_avatar
    NASDAQ Market News

    SOTIO Appoints Richard Sachse as Chief Medical Officer

    author_avatar
    NASDAQ Market News